Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niravam with SSRI/SNRI for Anxiety Disorders
NCT00266409Phase 4Completed
- Sponsor
- UCB
- Start
- Oct 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alprazolam in generalized anxiety disorder (GAD), panic disorder, sponsored by UCB. Started Oct 2005; status: completed.
02
Drugs
alprazolam
03
Conditions
generalized anxiety disorder (GAD)panic disorder
Beyond the preview
Go deeper on NCT00266409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266409.